Dimensional Fund Advisors’s Calithera Biosciences, Inc CALA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-23,814
Closed -$317K 3585
2021
Q4
$317K Sell
23,814
-26,966
-53% -$678K ﹤0.01% 3265
2021
Q3
$2.21M Sell
50,780
-17,743
-26% -$765K ﹤0.01% 2828
2021
Q2
$2.86M Sell
68,523
-3,133
-4% -$138K ﹤0.01% 2779
2021
Q1
$3.47M Sell
71,656
-2,406
-3% -$140K ﹤0.01% 2691
2020
Q4
$7.27M Sell
74,062
-303
-0.4% -$26.6K ﹤0.01% 2389
2020
Q3
$5.13M Sell
74,365
-5,052
-6% -$441K ﹤0.01% 2440
2020
Q2
$8.39M Sell
79,417
-648
-0.8% -$77K ﹤0.01% 2272
2020
Q1
$7.11M Buy
80,065
+4,384
+6% +$522K ﹤0.01% 2269
2019
Q4
$8.64M Buy
75,681
+1,500
+2% +$113K ﹤0.01% 2405
2019
Q3
$4.58M Buy
74,181
+922
+1% +$73.8K ﹤0.01% 2628
2019
Q2
$5.71M Buy
73,259
+2,339
+3% +$265K ﹤0.01% 2600
2019
Q1
$9.56M Buy
70,920
+8,718
+14% +$916K ﹤0.01% 2420
2018
Q4
$4.99M Buy
62,202
+12,811
+26% +$1.26M ﹤0.01% 2613
2018
Q3
$5.19M Buy
49,391
+9,776
+25% +$931K ﹤0.01% 2669
2018
Q2
$3.96M Buy
39,615
+15,995
+68% +$1.81M ﹤0.01% 2725
2018
Q1
$2.98M Buy
23,620
+14,502
+159% +$2.26M ﹤0.01% 2777
2017
Q4
$1.52M Buy
+9,118
New +$2.33M ﹤0.01% 2909

Other funds holding CALA

Dimensional Fund Advisors's CALA Position: Q1 2022 in Review

Dimensional Fund Advisors sold out of Calithera Biosciences, Inc (CALA) in Q1 2022, closing a stake of 23,814 shares — an estimated $317K sold.

Dimensional Fund Advisors first reported a position in CALA in Q4 2017 and held it in 17 quarters. The position peaked at $9.56M in Q1 2019. 54 funds tracked by Wall St. Rank hold CALA as of Q1 2022.

  • Dimensional Fund Advisors reported no remaining Calithera Biosciences, Inc position as of Q1 2022 after selling out during the quarter.
  • Dimensional Fund Advisors sold 23,814 Calithera Biosciences, Inc shares in Q1 2022, an estimated $317K.
  • Dimensional Fund Advisors first reported a position in Calithera Biosciences, Inc in Q4 2017 and held it in 17 quarters.
  • Dimensional Fund Advisors's Calithera Biosciences, Inc position peaked at $9.56M in Q1 2019.
  • 54 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q1 2022.

Based on Dimensional Fund Advisors's 13F filing for Q1 2022, filed 13 May 2022.